July 2004


The Crossroads Institute Newsletter


NEWS BRIEFS




More Than One-Third of U.S. Uses Natural Medicine

by Dr. Joseph Mercola

The government has suggested that more and more people are turning to meditation, herbs, yoga and other forms of alternative medicine because of lack of results with conventional care. One of the largest U.S. studies conducted on alternative medicine found that over one-third of American adults practiced some type of non-conventional medicine in 2002. The report was based on information from 31,044 interviews with adults aged 18 and older.

Researchers believed the results of the study pointed to the fact that more people are using alternative medicine. Also, it was apparent that an increasing number of people have turned to natural products like herbs or enzymes to help with chronic or recurring pain.

Experts suggested that people should not neglect conventional medicine in those instances where it has been proven to help certain conditions and also recommended consulting a doctor before practicing alternative medicine. Experts were concerned about the number of people turning to alternative medicine because they felt they were no longer able to afford the costs of conventional care.

Experts cautioned people who assumed that just because a product was natural that it was automatically safe to use. An example they cited was the 6.6 percent of people in the study found to use the supplement kava kava, which has been linked to liver disease.

Significant findings from the study include:

62 percent of the participants used some form complementary and alternative medicine over the past year for a specific medical condition, broken down as follows:

45 percent turned to some kind of prayer to help them heal in the past 12 months

There was a higher tendency for women to use complementary and alternative medicine than men

28 percent of the participants felt that conventional treatment would not help them

Based on the findings of this report, there appears to be a greater percentage of people turning to complementary and alternative medicine for their health needs.

Center for Disease Control National Center for Health Statistics May 27, 2004 (20-page Full-Text PDF Report)



 
Food Additives Linked to Hyperactivity in Children

Provided by South Bend Tribune on 6/23/2004


British researchers have found that artificial colorings and preservatives in food can drive hyperactive behavior in preschool children.

Child health specialists from the University of Southampton conducted a monthlong study of 277 3-year-olds.

During the first week, all youngsters ate foods free of such yellow dyes as tartrazine and sunset yellow, red dyes carmoisine and ponceau and the preservative sodium benzoate. Kids were randomly assigned in the second through fourth weeks to drink 10 ounces of fruit juice daily with or without 20 milligrams of colorings and 45 milligrams of preservatives.

Across the board, parents rated their children significantly less hyperactive when they weren't consuming the additives and more hyperactive when the chemicals were put back.

The study appears in the June issue of the Archives of Disease in Childhood.



Cells From Fat Tissue Turned Into Functional Nerve Cells
Provided by AScribe Newswire on 6/29/2004
by Duke University


DURHAM, N.C., June 1 (AScribe Newswire) -- Two years after transforming human fat cells into what appeared to be nerve cells, a group led by Duke University Medical Center researchers has gone one step further by demonstrating that these new cells also appear to act like nerve cells.

The team said that the results of its latest experiments provide the most compelling scientific evidence to date that researchers will in the future be able to take cells from a practically limitless source -- fat -- and retrain them to differentiate along new developmental paths. These cells, they said, could then be used to possibly treat a number of human ailments of the central and peripheral nervous systems.

The results of the team's latest experiments were published June 1, 2004, in the journal Experimental Neurology.

Using a cocktail of growth factors and induction agents, the researchers transformed cells isolated from mouse fat, also known as adipose tissue, into two important nerve cell types: neurons and glial cells. Neurons carry electrical signals from cell to cell, while glial cells surround neurons like a sheath.

"We have demonstrated that within fat tissue there is a population of stromal cells that can differentiate into different types of cells with many of the characteristics of neuronal and glial cells," said Duke's Kristine Safford, first author of the paper. "These findings support more research into developing adipose tissue as a viable source for cellular-based therapies."

Over the past several years, Duke scientists have demonstrated the ability to reprogram these adipose-derived adult stromal cells into fat, cartilage and bone cells. All of these cells arise from mesenchymal, or connective tissue, parentage. However, the latest experiments have demonstrated that researchers can transform these cells from fat into a totally different lineage.

Earlier this year, Duke researchers demonstrated that these adipose-derived cells are truly adult stem cells. As a source of cells for treatment, adipose tissue is not only limitless, it does not carry the potentially charged ethical or political concerns as other stem cell sources, the researchers said.

"This is a big step to take undifferentiated cells that haven't committed to a particular future and redirect them to develop down a different path," said Duke surgeon Henry Rice, M.D., senior member of the research team. "Results such as these challenge the traditional dogma that once cells become a certain type of tissue they are locked into that destiny. While it appears that we have awakened a new pathway of development, the exact trigger for this change is still not known."

For their latest experiments, the researchers demonstrated that the newly transformed adipose cells expressed many similar cellular proteins as normal nerve and glial cells. Furthermore, they showed that the function of these cells is similar to nerves.

They exposed these newly formed cells to N-methyl-D-aspartate (NMDA), an agent which blocks the activity of the neurotransmitter glutamate and is toxic to nerve cells. In response to NMDA, the newly induced cells died, a response similar to normal nerve cells under the same conditions. Physiologic insults -- such as stroke -- can stimulate NMDA receptors on nerve cells, which can cause nerve cell damage or death by over-stimulating them.

"We found that these induced adipose cells demonstrated an excitotoxic response to NMDA that corresponded with a loss of cell viability, which suggests that these induced cells had formed functional NMDA receptors similar to those found on nerve cells," Rice explained. "Recent studies have demonstrated that NMDA receptor activation by glutamate may induce early gene transcription in developing neurons as well as determine the rate of neuronal proliferation in the brain. Our findings suggest that these induced cells exhibit characteristics similar to developing neuronal tissue."

Now that the researchers are confident that these newly induced cells appear to have similar functions as nerve cells, the next step will be to see how they respond when they are implanted in a living animal model.

"While this is an important step forward, we still face many challenges to making use of these cells to treat human problems," said longtime collaborator Jeffrey Gimble, M.D., Pennington Biomedical Research Center at Louisiana State University System. "It seems probable that the potential first uses of such therapy would be in an acute setting, where you would have a window of opportunity right after a stroke, or spinal cord or peripheral nerve injury."

Until recently, it was believed that organisms were born with the full complement of neuronal cells, and that new neurons could not be formed. According to the researchers, the findings of their studies, as well as the experiments performed by others on bone marrow stem cells, opens up new possibilities for the treatment of nervous system disorders or injuries.

"We are trying to think about human disease in a new way," Gimble said. "Everyone is used to the concept of surgical, medical or pharmacological approaches to the treatment of disease -- we're looking at one of the next steps in biotechnology, which is using cellular therapies."

The current research was supported by the Owen H. Wangenstein, M.D., Faculty Research Fellowship of the American College of Surgeons. Other members of the Duke team included Shawn Safford, M.D., and Ashok Shetty, Ph.D.


 
Low DHEA linked to low libido

Provided by United Press International on 6/18/2004


CLAYTON, VICTORIA, Australia, Jun 18, 2004 (United Press International via COMTEX) -- Australian researchers said they have uncovered a new role for the hormone DHEA in signifying low libido.

Researchers at the Jean Hailes Foundation said they looked at 1,423 women ages 18 to 75 and found a strong relationship between low scores for desire among test subjects and low DHEA levels. They also found a correlation between low levels of the hormone and low levels of arousal and responsiveness.

"We undertook this study to determine whether women with low libido also had low levels of androgens," said Susan Davis, the foundation's director of research.

She added that sexual function is complex and not simply a function of hormones. Sexual desire also involves an intricate interplay of biological changes such as psychological influences including relationship factors, body image, aging, menopause, social and cultural expectations, Davis said.




 



 
Legal Drug Use Has Doubled in Decade
Provided by The Providence Journal on 6/27/2004
by G. WAYNE MILLER Journal Staff Writer

* Americans now average nearly a dozen prescriptions per person per year.


PROVIDENCE - Prescription drug use has reached record levels in Rhode Island and will keep rising for years. Having already transformed the face of health care, the trend will continue to affect patients, providers and insurers, experts agree.

"It's a mega-influence on the health-care system," says Dan Curran, pharmacy manager for Blue Cross & Blue Shield of Rhode Island, the state's largest health insurer. "It's going to be a dominant influence in the health-care debate for the foreseeable future."

Rhode Island is in step with a national trend that has seen prescription drug use rise dramatically for well over a decade.

Americans bought 3.4 billion prescriptions last year, according to IMS, a Connecticut-based consulting firm that processes data from drug manufacturers. That was nearly double the number of prescriptions purchased a decade ago -- and represented an average of about 11.8 prescriptions per person per year, an all-time high.

Never in history have so many people taken so many legal substances. Prescription spending last year in the United States, according to IMS, totaled $216 billion (wholesale) -- an increase of almost 12 percent in just 12 months. And there is no end in sight to the increase in use and cost.

"There has been a biomedical revolution," says Dr. Kathleen W. Wilson, author and internist at Ochsner Clinic Foundation in New Orleans.

Several factors are driving the trend.

Americans live longer than ever, and as they grow old they become increasingly susceptible to disease -- more and more of which can now be treated with medications. Aging baby boomers create demand for "lifestyle" drugs such as Viagra. Better and safer drugs are available for many disorders -- and new drugs are successful for ailments that were once untreatable. For certain conditions, pharmaceuticals have replaced surgery and other interventions as the treatment of choice.

And after investing hundreds of millions of dollars in developing a major new drug, manufacturers spend heavily to market it. Doctors offer copious free samples, courtesy of the drug makers. Major drugs have their own Web sites and even nicknames -- heartburn-reliever Nexium, for instance, is "the purple pill," and is featured at www.purplepill.com. And one can barely turn on the TV today or attend a professional sports event without seeing a drug ad.

"Pharmaceutical firms are in the business of maximizing profits," says John A. Vernon, a professor with the Center for Healthcare and Insurance at the University of Connecticut's School of Business. "Like any business, you market your products."

ALTHOUGH MEDICAID and other government programs track their subscribers' medications, no agency monitors all prescription drug use in Rhode Island, and private insurers do not release detailed numbers.

But data collected by NDCHealth, an Atlanta healthcare information services firm that tracks pharmacy sales, provide insights into prescription drug use in the state.

According to the firm, Rhode Islanders bought 14.7 million prescriptions in 2002, the last year for which complete data were available. That was an increase of 1.7 million prescriptions since 1999.

The per-person average in 2002 was 13.7 prescriptions purchased - - somewhat higher than the national average, but about the same as Pennsylvania and Massachusetts, which have high concentrations of elderly residents like Rhode Island. In 1999, the per-person average in Rhode Island was 13.1 prescriptions.

Rhode Islanders and their insurers in 2002 spent $937 million (retail) on prescription medications -- almost double the 1999 expenditure, an increase attributable in part to the higher costs of many new drugs. The average cost of a prescription in 2002 was $63.75, up from $39.28 in 1999. Consumers would not necessarily see such figures, since insurers pick up some or all of the cost.

At the Journal's request, NDC ranked the 100 best-selling drugs in Rhode Island last year.

* With 478,921 prescriptions, Lipitor was the most-prescribed (nationally, it was number two). The drug lowers cholesterol, a factor in heart disease, the leading cause of death in Rhode Island and the nation. Lipitor sales in Rhode Island last year surpassed $40 million (wholesale), cost-wise more than double any other drug.

* Second in Rhode Island, with 367,804 prescriptions, was the painkiller hydrocodone with acetaminophen -- sold as Vicodin, among other brand names. Hydrocodone was the most-prescribed drug in the United States last year, with almost 86 million prescriptions.

* Third and fourth in Rhode Island were lisinopril and atenelol, both of which are prescribed for high blood pressure, a factor in strokes, the state's and nation's third-leading killer.

* Fifth in Rhode Island was amoxicillin, an antibiotic.

* The remainder of Rhode Island's top 20 included drugs for heartburn and ulcers (Nexium); for depression, anxiety, panic and related disorders (Zoloft, Xanax, Prozac); asthma (albuterol); and thyroid ailments (Synthroid).

AN AMERICAN born in 1900 could expect to live to 47; today, a typical newborn will live past 77, and every year life expectancy increases. This change has been particularly evident in Rhode Island, where 14.5 percent of all residents in the 2000 census were 65 or older -- making the state the sixth oldest, by percentage, in the nation.

"We've got an aging and a graying population and with that comes increased health issues. And the majority of those issues require some combination of drug therapy," says Charles Mahoney, administrative director of pharmacy services for Rhode Island, Miriam, and Bradley hospitals.

In many instances, says Kate L. Lapane, an associate professor at Brown Medical School who specializes in drug use by the elderly, patients suffer from more than one disorder. It is not uncommon to find a patient with heart disease, diabetes and cancer.

"Each of these conditions can require multiple medications," Lapane says. "And as you live longer with the diseases, it may require [even] more complicated drug regimens to control and manage."

The inevitable result, as Lapane witnessed with her grandmother, who took at least ten medications for heart disease and diabetes: greater drug use.

And that use will intensify as the baby boom generation advances toward retirement, swelling the ranks of America's elderly population. According to Census Bureau projections, 39.7 million Americans will be 65 or older in 2010 -- about 4 million more than today. By 2025, that number will soar to 63 million Americans -- and of those, more than 7 million will be 85 or older.

EVEN WITH YOUNGER patients, the trend is toward earlier drug treatment of certain disorders. Dr. Yul D. Ejnes, associate professor at Brown and past president of the Rhode Island Medical Society, cites high blood pressure as an example.

When Ejnes began practice as an internal medicine specialist in the late 1980s, doctors believed that blood pressure was acceptable as long as the systolic reading (the first number in the reading) was below age plus 100. Now, Ejnes says, 140/90 is the benchmark for everyone -- with specialists debating whether 130/80 would be a healthier marker.

"We're getting more aggressive in the treatment of high blood pressure," Ejnes says. "Treatment thresholds are going down."

With the introduction of new drugs, doctors have more effective ways of lowering blood pressure than ever before. It is no coincidence that lisinopril, sold under the brand names Zestril and Prinivil, is the third most-prescribed drug in Rhode Island (and sixth in the nation), with nearly a quarter-million prescriptions filled last year.

New drugs are also replacing surgery as the treatment of choice for certain disorders. Ejnes cites ulcers as an example.

Decades ago, doctors treated ulcers with milk and cream, and when that failed, they resorted to surgery. Antacids replaced dairy products -- but surgery remained an option. With the recent advent of a class of drugs called proton pump inhibitors -- including Nexium, the 16th most prescribed drug in Rhode Island -- surgical treatment has virtually disappeared.

"I don't have a patient who has ever undergone that kind of surgery in recent years," says Ejnes. In terms of overall health- care costs, this is an instance when drug treatment can be cheaper.

AND THEN THERE is the profit motive.

Drug manufacturing is big business: led by Pfizer, with $45 billion of sales, the top 10 pharmaceutical firms alone sold more than $200 billion in drugs last year. Among Pfizer's best-selling products are Lipitor, Zoloft, and Viagra.

With an annual return of 17 percent on revenues, drug-making is the country's most profitable business, according to the Kaiser Foundation. Pfizer's last year returned almost $4 billion in profit to its shareholders.

A study cited by the University of Connecticut's Vernon found that it costs a drug maker an average of $802 million to bring a major new drug to market. But when a drug hits, that investment pays off -- big time. A highly successful drug like cholesterol-lowering Lipitor rang up more than $9 billion in sales last year.

To make money, a drug first must work, of course.

But most drugs have competition. Lipitor, for instance, is up against cholesterol-lowering drugs made by Novartis (Lescol), Merck (Zocor), and Bristol-Myers Squibb (Pravachol). Each of these companies rings up more than $20 billion a year in sales.

Like any other business, drug firms aggressively market their products. The firms field sales forces that call on doctors. They sponsor conferences and pay for health-care professionals to attend. They provide free samples.

According to a November 2001 study by California's Kaiser Family Foundation, pharmaceutical manufacturers in 2000 provided nearly $8 billion (retail) in free drug samples to U.S. doctors -- $3 billion more than in 1996.

Meanwhile, encouraged by the growth of the Internet and by a government ruling in the 1990s that allowed drugs to be advertised on TV, companies now pitch their products directly to consumers. During the 1996-2000 period studied by Kaiser, spending for direct- to-consumer advertising rose almost 33 percent -- from $791 million to nearly $2.5 billion, and indications are that spending keeps climbing. Pfizer alone last year spent $664 million on ads directed at consumers, according to Pharmaceutical Executive magazine.

According to Blue Cross & Blue Shield's Curran, many patients go to their doctor's office with a diagnosis and a request for a drug - - which they get. "People say, 'I saw the purple pill on TV -- I think I have those symptoms, can you give me that?' And doctors want their patients to be healthy and they want their patients to be happy with them," Curran says.

Direct-to-consumer advertising has led to a measure of abuse, says Stephen J. Kogut, assistant professor in the University of Rhode Island's Department of Applied Pharmaceutical Sciences. "Patients who may or may not need a medication may demand it anyway," he says.

But direct-to-consumer advertising has also helped to create a more knowledgeable consumer -- and that can be a good thing, he maintains.

"Some would say that it interferes with the patient-provider relationship," Kogut says, "but in this country there's a right to disseminate information that is not inaccurate or misleading."

WITH DOZENS of new drugs set to enter the market, projections show prescription drug use continuing to climb. Medco, a New Jersey- based pharmacy benefits manager, anticipates annual increases of three to six percent in numbers of prescriptions written through 2006 in the United States.

Costs are projected to soar, too.

The Federal Centers for Medicare and Medicaid Services, which analyzes all prescription drug use in the United States, predicts that the total cost of prescription drugs will rise at an annual rate of 11 percent through 2013.

Rhode Island, experts say, will stay firmly inside the trend.

And sooner or later, experts predict, that will force a public debate on a multitude of issues, including: the cost of drugs; who pays for drugs; access to new drugs; drug imports; drug safety; and better communication among patients, doctors, insurers, and pharmacists.

"It's a train that's coming down the track," says Curran. "There's a crying need for public policy."



RESEARCH AND ADVANCEMENTS




Burning mouth syndrome
Proper diagnosis helps patients extinguish flames

CHICAGO (June 14, 2004) - A burning sensation on your tongue or lips that gets worse as the day goes on, may drive you crazy, and it may mean you have Burning Mouth Syndrome (BMS), a difficult to diagnose condition. BMS affects approximately one percent of the population, but it could be as high as five percent, according to an article in the June 2004 issue of AGD Impact, the newsmagazine of the Academy of General Dentistry.

In approximately 30 percent of the cases, systemic problems, such as diabetes, vitamin deficiency, gastrointestinal reflux disorder, anemia or side effects from medications that cause dry mouth, may cause BMS. In 70 percent of the cases, doctors are unable to pinpoint the source, but know that it occurs more often in women than in men.

"Patients ask how BMS is diagnosed, how it is treated and if it's related to cancer," says Andres Pinto, DMD, lead author of a BMS recent report found in General Dentistry, the AGD's clinical, peer-reviewed journal.

"Dentists diagnose BMS by ruling out chronic problems," says Dr. Pinto. He assures patients that BMS is not and cannot cause cancer. For the 70 percent of the population where no diagnosis can be pinpointed, your dentist will treat the symptoms through topical rinses, anesthetics, anti-depressants in low doses or capsaicin (a red pepper derivative).

"Your dentist may place you on an antidepressant, which masks the burning sensation that occurs on the tongue by changing the brain chemicals," says Trey Petty, DDS, FAGD and AGD spokesperson. "Capsaicin, another alternative, works by overwhelming the mouth by providing the pain with a distraction."

Both experts agree, while BMS is hard to diagnose and is relatively rare, the symptoms may eventually disappear. Patients experiencing an ongoing burning sensation should immediately see their dentist.

  • Do You Have BMS? Check For:
  • Burning sensations in mouth area
  • Dry mouth
  • Altered taste perception
  • Changes in eating habits
  • Irritability
  • Depression
  • Changes in medications


Celiac disease too often missed; report highlights unusual symptoms

by LAURAN NEERGAARD AP Medical Writer


WASHINGTON (AP) - Celiac disease isn't nearly as rare as once thought: millions may have the severe digestive disorder, most undiagnosed and thus suffering unnecessarily, an expert panel told the U.S. National Institutes of Health on Wednesday.

On average, patients suffer symptoms for 11 years before they're diagnosed, because the disease, triggered by the gluten protein found in certain grains, is so little understood even by physicians, the panel found.

Simple new blood tests can help diagnose celiac more easily today than just a few years ago, but only if doctors know to order them - and many patients complain of symptoms very different than those long taught in medical school.

``We have a very effective treatment - a gluten-free diet,'' said Dr. Charles Elson of the University of Alabama at Birmingham, the panel chairman. ``But if physicians don't recognize when to test for the disease, patients are going to suffer needlessly.''

The panel urged NIH to launch a major education campaign for doctors and the public to improve awareness of the myriad symptoms, a recommendation that won applause from celiac advocacy groups.

While the federal agency had no immediate comment on an education campaign, it convened the three-day meeting in part to raise the profile of the little-known disease, and reports from such NIH-convened panels often influence physician practices.

Celiac disease occurs in people with a genetically spurred intolerance of gluten, found in such grains as wheat, barley and rye. When they eat gluten, the immune system reacts improperly and damages the inner lining of the small intestine, blocking proper nutrient absorption. Untreated, it can lead to serious vitamin deficiencies, bone-thinning osteoporosis, occasionally even gastrointestinal cancers.

Doctors long thought of celiac as a childhood ailment - as one NIH panelist put it, too-small youngsters with large pot bellies. But it can show up at any age, and is most often diagnosed in middle-aged Americans.

Classic symptoms include diarrhea, abdominal pain, gas, bloating and weight loss.

But many patients don't experience those signs and instead report so-called atypical symptoms, including a blistering, itchy skin rash, anemia, short stature, delayed puberty, infertility and tooth enamel defects.

In fact, patients without the classic intestinal symptoms may be the most common celiac sufferers today - and recognition of that fact, thanks in part to the new blood tests, has spurred higher prevalence estimates, Elson explained.

Most at risk are relatives of celiac sufferers, people with Type 1 diabetes or Down syndrome, and people with other autoimmune disorders.

Most patients recover with a gluten-free diet for life. But gluten can be hidden in foods not commonly associated with grains, such as some candies and soups, making adherence difficult.

The panel also urged better testing and labeling of gluten in foods. A bill to improve food labeling is pending in Congress.



 


Diet helps kids with epilepsy
Provided by AAP on 6/21/2004
by David Stringer, PA News


A revolutionary low-carbohydrate diet could dramatically ease the effects of epilepsy in children and reduce the need for sufferers to take drugs, researchers claimed.

Pioneering work at London's Great Ormond Street Hospital has shown that almost half of youngsters following a high-fat Ketogenic diet have reported a 50% reduction in seizures.

Preliminary results of the two-year study reveal that 42% of epileptic children on the diet for three months have at least 50% fewer seizures.

A total of 19% report a reduction in seizures of 75% or more.

Paediatric neurologist Dr Helen Cross, of the hospital, told ITV1's Tonight with Trevor McDonald: "Following these results, we hope the Ketogenic diet will be recognised as an established alternative treatment for any child with challenging and resilient epilepsy.

"If the diet was introduced more widely across the UK it could have huge benefits in the future by reducing the need for medications.

"Unfortunately, there are only a handful of dieticians in the UK who have the expertise and resources to deliver it."

In trials involving 31 children, doctors were able to reduce the anti-epileptic medication of 42% of patients after three months.

Parents also reported improvements in alertness, awareness and responsiveness in three quarters of the youngsters.

The tests, conducted with the Institute of Child Health and the National Centre for Young People with Epilepsy, have involved children adhering to either a classical version of the Ketogenic diet or one which includes prescription-only medium chain triglyceride supplements.

Both diets encourage the children to eat cream, butter, eggs or other fats with proteins, whilst avoiding portions of carbohydrates such as pasta or potatoes.

Wendy Winful's six-year-old daughter Francesca suffered from between 60 and 70 seizures a week before starting the diet, but now suffers only around six a week.

"She is so much more alert, much more responsive. Last week she had six seizures, she used to have twice that in a day," said Mrs Winful, of London.

"Francesca will now answer much more quickly, she told a joke the other day and that was fantastic. She's never done that before."

Doctors believe that the diet is suitable only for children with drug resistant epilepsy and admit that the treatment is not effective for every child.

 


 
Maternal Thyroid Disorder Linked With Children's Learning Disabilities; Experts Call for Thyroid Testing for Expectant Mothers;

Provided by AScribe Newswire on 6/30/2004
by Environmental Media Services

WASHINGTON, June 23 (AScribe Newswire) -- Citing a scientific study linking abnormal thyroid-related hormone levels in expectant mothers with developmental problems in their babies, a panel of experts today recommended thyroid screening as part of routine health care for all pregnant women and women who are planning to have children.

The experts referred to a study published in the New England Journal of Medicine finding that children 7-8 years old had I.Q. scores 7 points lower if their mothers had slightly low thyroid hormone levels or even normal thyroid hormone with slightly elevated levels of thyroid stimulating hormone- a condition known as subclinical hypothyroidism - during pregnancy.

"Thyroid hormone is essential for fetal brain development," said Ted Schettler, a physician at the Boston Medical Center and science director for the Science and Environmental Health Network. "We've known for a long time that obvious thyroid deficiency can impair normal brain development but it's the children of mothers without symptoms that we need to worry about as well. We ought to be more aggressively looking for subclinical hypothyroidism in mothers because it's affecting the neurological development of babies."

In subclinical hypothyroidism, the mother does not exhibit symptoms of hypothyroidism but the fetus may still be affected. Two and one-half percent of pregnant women are subclinically hypothyroid and 100,000 babies are born each year to these women, Schettler said.

James Haddow, professor of pediatrics at the University of Vermont School of Medicine and lead author of the study in the New England Journal of Medicine, said that, once detected, the problem can be easily corrected with a daily pill.

"Hypothyroidism is a perfect example of something that's easy and inexpensive to detect and to treat once it's detected," said Haddow. "It makes good sense to incorporate [thyroid screening] into prenatal care."

Jane Browning, executive director of the Learning Disabilities Association of America, called on doctors to make thyroid screening a routine part of a well-woman exam, and said it should be part of every pre-pregnancy and pregnancy exam.

Browning discussed her experience raising a developmentally disabled child. Her son recently graduated with a high school certificate at age 21. Because of his disability, he requires a professional companion and assistance with basic tasks such as showering and shaving.

"You think it's hard to find a job without a college degree. Try finding work without a high school diploma," said Browning. "The cost to families is high. The cost to society is high. It's twice as expensive, for society, to school someone who has a learning disability."

"Moms and moms-to-be, please make sure you get your thyroid level tested," Browning urged. She said home testing kits are available for expectant mothers who cannot find a doctor to provide a test.

The panelists said synthetic chemicals in the environment may be contributing to reduced levels of maternal thyroid hormones or abnormal thyroid hormone function. "There are classes of compounds in the environment that affect thyroid function in ways we could not have imagined 10 years ago. In the lab we're seeing what appear to be links between some of these compounds and brain development which could result in learning and developmental disabilities in humans," said Thomas Zoeller, professor of biology at the University of Massachusetts-Amherst.

PCBs, perchlorate from rocket fuel, and a class of flame retardants called PBDEs are all known to interfere with thyroid function or thyroid hormone action. PBDEs in particular have received a great deal of attention in the press, as studies have found high levels of the chemicals in household dust and in the human body.

"We have had an extraordinary rise in PBDEs throughout the population," said Schettler, referring to the presence of these synthetic chemicals in the human body.

Schettler said that PBDEs are very similar to PCBs, which have been banned in the United States since 1976, and should be treated as an equal threat and replaced with safer alternatives. "There's no need to repeat the same mistake we made with PCBs," he said.




 
Stress does not exist in a vacuum

Provided by Saint Paul Pioneer Press on 7/1/2004



Stress management as now practiced is a failure. How's that for a statement from the Director of the Institute for Stress Management? I now believe that I and many other professionals in the field have missed the point. Or have approached it from the wrong direction and emphasis.

Yes, stress exists and has become epidemic. Yes, it weakens our immune system and contributes to the development of mental and physical diseases. Yes, stress accounts for as much as 80 percent of all visits to primary physicians. So, why do I say stress management has failed? We have emphasized the wrong approach and have treated symptoms instead of causes.

Stress is the result of something. It does not exist in a vacuum. It is how we live and metabolize our lives that causes the stress we experience. It is a combination of how we allow events and situations to affect us. And, how we respond to those events and situations appropriately or inappropriately.

Thus, the solution is to concentrate on the causes, not the effects, of stress. That calls for behavior changes, for developing better life management skills. If we change the behaviors that result in stress, if we develop the skills that lower or stop stress, there is no stress to manage.

Many who suffer from high levels of stress want magic bullets or quick fix solutions. When asked about changing how they live, what they believe and how they respond to stress, they balk. Many like the adrenaline rush and excitement of a fast-paced life. They know the importance of a healthy diet, regular exercise, planned relaxation, time off and the perils of anxiety and anger. Still, they believe, given how they choose to live, they have no choice. They feel they must accept the stress they experience as the price for the life they want. If they will not change behaviors and attitudes, they are right.

That is how traditional stress management has failed. Magazines at store checkout lines trumpet "10 ways to conquer stress." When you read the articles or look at their quickie checklists, they all name the same approaches.

If the solution to stress is so common, why are so many of us stressed out? Because we want to have our cake and eat it, too. The irony is, we can.

If: We will make some trade-offs, exert some discipline and take responsibility for our beliefs and actions. The reality is, that is why so many fail. They do not want to make trade-offs. They want life as they want it, on their terms, at their pace. Discipline and responsibility are unwelcome words in the vocabulary of those wanting quick fixes.

So, what is the solution? There is none for those unwilling to change and take responsibility for their current situation. There is a solution for those willing to look realistically at their current situation. They must identify what they want to experience and plan how to close the gap between the current reality and the desired state of expression.

The solution will probably involve changing stress-inducing behaviors and attitudes. It will likely include learning new coping skills, adjusting or dropping old response patterns, and recognizing limits and making trade-offs.




ALZHEIMER NEWS


Alzheimer's May Leave Some Forms of Memory Intact

by Howard Hughes Medical Institute


CHEVY CHASE, Md., June 9 (AScribe Newswire) -- Howard Hughes Medical Institute (HHMI) researchers have made the surprising discovery that people with Alzheimer's disease retain the capability for a specific form of memory used for rote learning of skills, even as their memories of people and events are extinguished.

The scientists' discovery suggests new strategies to improve training and rehabilitative programs that may bolster the retained cognitive function of those with Alzheimer's disease as well as healthy older people.

"From this and other studies we have done, it appears that a number of brain systems are more intact in Alzheimer's than we had anticipated," said Howard Hughes Medical Institute researcher Randy L. Buckner at Washington University in St. Louis. "The findings suggest that if we can help people use these brain systems optimally by providing the right kinds of cues or task instructions, we may be able to improve their function."

In an article published in the June 10, 2004, issue of the journal Neuron, Buckner and Cindy Lustig, also at Washington University, compared implicit memory capabilities in young adults, healthy older adults and those in the early stages of Alzheimer's disease.

Buckner said that although researchers have used behavioral studies to distinguish implicit memory -- that used to recall procedures like tying a shoe -- from the explicit memory -- that used to recall past associations and events -- the neurobiology underpinning implicit memory remains a mystery. In anatomical terms, the kind of explicit memory that is severely impaired in Alzheimer's disease depends on the condition of the medial temporal lobe, including the hippocampus, said Buckner. "The form of memory that enables us to learn a cognitive skill is less well understood, although it is thought to depend on areas of the cerebral cortex," said Buckner.

For their study, Lustig and Buckner recruited 34 young adults, 33 healthy older adults, and 24 older adults in the early stages of Alzheimer's disease. They designed their study to compare the implicit memory capabilities of younger and older people both with and without Alzheimer's symptoms. Lustig and Buckner presented the subjects with a series of words and asked them to decide whether the words represented living or non-living objects. They also hoped that their studies would provide a clearer picture of the regions of the brain that are employed in such tasks.

"For this task, we found that all three groups showed a significant reduction with practice in the time required to decide on a word, which is the hallmark of implicit learning," said Buckner. While the younger adults were faster in performing the tasks, all three groups showed a robust reduction in time with practice, he said.

The researchers next asked the subjects to repeat the classification task as their brains were scanned using functional magnetic resonance imaging. "What was surprising and novel in this study is that the brain region with the greatest activity during the task was the high-level region of the frontal cortex," said Buckner. "We didn't expect this because high-level cognition is affected in Alzheimer's disease. These results suggest that despite the damage to these areas in Alzheimer's, certain memory processes that seem to depend on them remain fundamentally intact."

The researchers found that the reduction in time required to perform the classification task correlated with a reduction in activity in frontal cortex. This reduction is a characteristic property of a brain region that is adjusting its activity to function more efficiently as it becomes accustomed to a particular task. "This finding suggests there is a link -- although it doesn't prove it -- between activity reductions in frontal cortex and this type of learning," said Buckner.

Although the findings are preliminary, Buckner believes the studies point to a promising approach for training and rehabilitation. "Our hope is that by demonstrating the availability of these systems, this knowledge will be translated to cognitive training programs for the healthy elderly and those with forms of dementia, which we just had not anticipated when we began this work," Buckner said.

At this point it appears that structured training programs might be the most effective approach. "Our earlier work had shown that if you leave older adults to form their own approach to a task spontaneously, that's perhaps the least helpful situation," he said. "Whereas, if you constrain the task and give very directed goals, it helps older adults recruit those remaining neural areas. In this study, we've shown that it is possible to tap into high-level cognitive areas that show preserved memory function." Further research, said Buckner, will include studies to understand the neural mechanisms underlying implicit memory, to pinpoint how they are compromised in both the healthy elderly and those with Alzheimer's disease.



The Howard Hughes Medical Institute was established in 1953 by the aviator-industrialist. HHMI's principal mission is conducting basic biomedical research, which it carries out in collaboration with more than 66 universities, medical centers and other research institutions throughout the United States. Its more than 300 investigators, along with a scientific staff of more than 3,000, work at these institutions in Hughes laboratories. The Institute also has a philanthropic grants program that is strengthening science education and training, from elementary school through graduate and medical school. It also supports the work of biomedical researchers in many countries around the globe.




ALLERGY NEWS




Antioxidants Linked to Lower Asthma Risk

American Journal of Respiratory and Critical Care Medicine


A large study of survey data on youths under 17 has shown that increases in intakes of antioxidants serum beta-carotene, vitamin C, and the trace mineral selenium were associated with a lower risk of asthma prevalence. The results were reported in the February 1, 2004, issue of the American Journal of Respiratory and Critical Care Medicine.

Even stronger asthma associations for these antioxidants were found in subgroups of young people exposed to passive smoke. Researchers studied U.S. national survey data on 6,153 young people four to 16 years old. They found that serum vitamin E had little or no association with asthma, but an increase in beta-carotene was associated with a 10% reduction in asthma prevalence in those not exposed to smoke and a 40% reduction in those who were exposed to passive smoke. The pattern for vitamin C was similar. An increase in selenium was associated with a 10-20% decrease in asthma prevalence. In youths with passive smoke exposure, investigators found a 50% reduction in asthma associated with selenium.

The study was conducted by Dr. Rachel N. Rubin and colleagues at Cornell University (Ithaca, NY, USA).





BRAIN RESEARCH




MOODY BRAINS: Music, art, food and more really do turn people on and off

Provided by Detroit Free Press on 6/27/2004
by ROBERT S. BOYD

Love chocolate? Hate being snubbed? Turned on by sexy pictures? Turned off by an ugly face?

Scientists are making rapid strides in identifying where and how your brain handles such feelings, from the overwhelming flush of romantic love to the shivers a favorite piece of music sends down your spine.

Brain researchers are using technologies that measure blood flow, electromagnetic radiation and other events going on in your head when you experience strong emotions. They believe their work can help deal with problems such as obesity, drug addiction, sex crimes and mental disease.

Their effort has also inspired a new field of "behavioral finance" or "neuromarketing," which studies what happens in the heads of consumers, investors and gamblers as they decide whether and how much risk to take.

"Studies of the brain are teaching us how, why and when investors make decisions to buy and sell," said Dr. Richard Peterson, a psychiatrist and financial consultant in San Francisco.

Advertising agencies are beginning to use brain imaging to study what goes on in consumers' minds when they look at a product or an ad, Peterson said. The goal is to help create more effective commercials.

Justine Meaux, the research director of the BrightHouse Neurostrategies Group in Atlanta, described a neuromarketing experiment recently at the "Human Brain Mapping 2004" conference in Budapest.

Magnetic brain scans of 13 volunteers showed that one area of their brains, the medial prefrontal cortex, lit up when they viewed images of fruits, cars, sports or hobbies that they especially liked, Meaux reported. Pictures of other objects didn't have the same effect.

Neuromarketing worries critics such as Gary Ruskin, the executive director of Commercial Alert, an organization founded by independent presidential candidate Ralph Nader that works to block advertising in schools and public areas.

"It is wrong to use a medical technology like brain scans for marketing," Ruskin said. More effective marketing of food or tobacco products could lead to more obesity or smoking, he cautioned.

Brain researchers' most powerful tools are Positron Emission Tomography and functional Magnetic Resonance Imaging, two complementary technologies that reveal the living brain at work. Both are found in most hospitals and neurological laboratories.

In the PET system, a person lies in a scanner while a mild radioactive fluid traces the flow of blood through his or her brain. More blood flows to brain cells, or neurons, that are most active at the time. A radiation detector identifies the cells that are turned on when a person experiences emotions such as fear, hunger, pleasure or disgust.

An fMRI, in contrast, uses powerful magnets and radio waves to create pictures of the brain in action. The extra blood flowing to activated brain cells carries more oxygen, which alters the magnetic field in that area. Radio waves pin down the exact location of the magnetism. Color images -- red for high intensity, yellow, green and blue for lower levels -- identify which brain structures are busier than others.

An even newer technique is magnetoencephalography (MEG, for short), which identifies tiny magnetic fields generated by electrical activity in neurons. MEG can time events to thousandths of a second, far more precisely than fMRI. Researchers say knowing when things occur in the brain is as important as knowing where they happen.

Studies have shown that certain brain structures play relatively greater roles in one emotion compared with another. For example, the amygdala, a walnut-sized organ buried deep in the brain, is associated with fear. The caudate nucleus, a tail-shaped mass of brain cells linked to movement, lights up when a person feels disgust.

Researchers point out that these structures don't act in isolation. Rather, the brain cells in each area influence -- and are influenced by -- other regions through networks of complex circuits linking billions of neurons.

Antonio Tataranni, a nutrition expert at the National Institutes of Health's branch office in Phoenix, is trying to unravel the connections between human brain activity and obesity. He found that six different regions in the brains of 55 volunteers responded in different ways depending on whether the subjects were hungry or full, fat or thin.

Tataranni took PET scans of the volunteers after they had gone without food for 36 hours, and again after they were fed a hearty meal. He discovered significant changes in the way six different sites in the volunteers' brains responded to hunger and fullness.

"Different regions of the brain work in concert to orchestrate normal eating behaviors and conspire to produce obesity and other eating disorders," he said.

Of special interest were 11 formerly obese men and women. Tataranni said this group is "at high risk for relapse" because their brain scans resembled those of fat people more than thin ones.

"We are now working on the vastly more important and complicated questions of which of these neural differences may cause obesity in the first place," Tataranni said.

In another experiment, Dana Small, a neuroscientist at Northwestern University in Evanston, Ill., took PET scans of volunteers while feeding them pieces of chocolate. Five areas in their brains lit up while the participants were still hungry, but three different regions were activated when they had eaten too much.

Small concluded that the brain has separate motivational systems -- one that's active when a person is hungry and the other for when he or she is full.






CHINESE MEDICINE



Acupuncture Needles Away Wrinkles

Provided by The Gazette on 6/7/2004
by BILL RADFORD THE GAZETTE


An ancient discipline is providing an alternative to face-lifts as aging baby boomers seek to turn back the clock.

Facial acupuncture, or the acupuncture face-lift, is nothing new in China, where acupuncture originated thousands of years ago.

But it's gaining popularity in the United States, part of a trend toward quick, nonsurgical cosmetic treatments.

"Women don't want surgery," says Martha Lucas of the Colorado Center of Traditional Medicine in Denver. "They want something not too invasive, so they're looking into alternatives."

According to traditional Chinese medicine, good health is the result of the free and balanced flow of life energy, or qi (pronounced "chee"), through pathways called meridians.

Needles are placed at certain points to correct the flow of qi, alleviating pain and other ailments.

The National Center for Complementary and Alternative Medicine, part of the National Institutes of Health, states that research shows acupuncture is beneficial in treating a variety of health conditions.

The National Council on Health Fraud, though, calls it an unproven treatment based on "primitive and fanciful concepts of health and disease."

As a cosmetic treatment, "acupuncture can rejuvenate the skin cells, get rid of fine lines, bring more energy and blood flow to the face," says Nawei Jiang, of Nawei's Acupuncture Clinic in Colorado Springs.

The results are not as dramatic as a surgical face-lift, but there's also no downtime or pain, and it costs less.

"It's a subtle change, but you can see the wrinkles are less and the face looks and feels more vibrant," says Randel Wing, of the Acupuncture Clinic in Colorado Springs.

Kay Atwood, who is in her 50s, considered getting surgery, "but when I talked to the plastic surgeon, he said I'm really not that bad yet, that I'm not sagging enough yet to make it worthwhile."

The Woodland Park woman also looked into Thermage, which uses radio-frequency waves to tighten the skin, but she was scared off by reports of how painful it can be.

So she turned to acupuncture, which gave her relief from shoulder pain years ago. She also uses it for overall health.

"I like to pretty much go natural and holistic in my health care," she says. "I don't even take aspirin."

Less than midway through the eight treatments by Wing, Atwood was seeing improvement.

She says the crease between her eyes had diminished, as had other fine lines.

The process is not painful, she says.

"You don't really feel anything when he puts the needle in. Then he'll twirl it a bit to get the qi flowing and then you feel like kind of a little charge."

The acupuncture face-lift is a small part of Wing's practice, but cosmetic acupuncture is a primary focus of Lucas' business in Denver.

Wing uses less than a dozen needles on the face, but Lucas uses 60 or more.

"I have specific points with specific needling techniques that I use every time," Lucas says. "It's kind of like follow this recipe, get good results."

The process involves placing needles elsewhere on the body as well as on the face. As a result of accessing the qi, "people feel an overall body rejuvenation," Lucas says.

One of her patients, who entered menopause a couple of years ago, says she stopped having hot flashes and night sweats after undergoing the facial-acupuncture treatments. "As far as I can tell," Lucas says, "this is the only cosmetic treatment that improves your health."






MEMORY




How Brain Gives Special Resonance to Emotional Memories

by Duke University

DURHAM, N.C., June 9 (AScribe Newswire) -- If the emotional memory of a traumatic car accident or the thrill of first love are remembered with a special resonance, it is because they engage different brain structures than do normal memories, Duke University researchers have discovered.

Their new study provides clear evidence from humans that the brain's emotional center, called the amygdala, interacts with memory-related brain regions during the formation of emotional memories, perhaps to give such memories their indelible emotional resonance.

The researchers said their basic insights could contribute to understanding of the role that the neural mechanisms underlying emotional memory formation play in post traumatic stress disorder and depression.

The study by Florin Dolcos, Kevin LaBar and Roberto Cabeza was reported in the June 10, 2004, issue of the journal Neuron. Dolcos is a research associate in the Brain Imaging and Analysis Center and LaBar and Cabeza are, respectively, assistant and associate professors of psychological and brain sciences. They are also faculty in the Center for Cognitive Neurosciences. Their research was supported by the National Institutes of Health.

According to Dolcos, in their experiments the researchers were seeking evidence for the "modulation hypothesis," which holds that the brain's emotional and memory centers interact during the formation of emotional memories.

"The basic idea was simple: to find evidence supporting the notion that the brain's emotional region modulates activity in the memory regions to form an emotional memory," said Dolcos. "This idea was supported by animal research, but the evidence from neurologically intact humans was scarce and indirect. So, our goal was to find the right method that would allow us to demonstrate that this phenomenon happens in humans, too," he said.

In their study, the researchers sought to establish that the memory-enhancing effect of emotion is due to interaction between emotion- and memory-related brain regions. Thus, they first exposed volunteer subjects to a collection of pictures that evoked both positive and negative emotions and those that were neutral. Emotional pictures depicted such negative events as aggressive acts or injured people and such positive events as romantic scenes or sporting triumphs. Neutral pictures included such subjects as buildings or scenes of routine shopping.

While viewing the emotional and neutral pictures, participants' brains were scanned using functional magnetic resonance imaging. Such imaging involves the use of harmless magnetic fields and radio signals to measure blood flow to individual brain regions, which reflects greater activity in those regions. Then, following the scanning session, the researchers tested participants' memory for the images they viewed during the scanning.

Two important features distinguish the new study from previous functional neuroimaging studies, said the researchers. First, to identify the brain regions associated with the memory-enhancing effect of emotion, the study linked behavioral memory performance for emotional and neutral pictures to brain activity during memory formation. Second, to delineate the contribution of the emotion and memory-related regions during emotional memory formation, the study used precise anatomical methods, which involved tracing of these regions on each subject's brain image.

As expected, analysis of the behavioral data revealed evidence that the memories of emotional images were more strongly encoded than the neutral ones. And importantly, the brain scans showed that the emotional memories evoked activity in the amygdala as well as the "medial temporal lobe memory" structures. Specifically, these structures include the hippocampus and associated regions. Moreover, according to Dolcos, the analysis revealed a significant correlation between the strength of activity in the emotion- and memory-related brain regions.

"We found evidence that the interaction between the emotional and memory regions occurred more systematically and consistently during the formation of emotional memories than during the formation of neutral memories," Dolcos said. "More specifically, we found that the subjects showing greater successful encoding activity in the emotional region also had greater activity in the memory regions," said Dolcos.

Said Cabeza of the findings, "Other studies have focused on the general enhancing effects of emotion on memory, and the evidence for the modulation hypothesis was disparate and inconclusive. Thus, this is the first direct evidence for the modulation hypothesis in humans; and the first report of differences in sensitivity of the medial temporal lobe regions to encoding of emotional versus neutral stimuli."

What's more, said Cabeza, "We also found indications that some regions within the medial temporal lobe may actually be more specialized for encoding neutral information. We don't know exactly what the processes involved are, or why these regions are engaged. But we speculate that the regions that were more activated for emotional stimuli are involved in semantic processing of the meaning of the images, whereas those that are more activated by neutral stimuli reflect perceptual processing."

Thus, said Cabeza, the findings not only establish the functional link between the emotional and memory areas; but also hint at differences within the memory areas that should be explored with further studies. As part of their research, the authors are now exploring the role of these brain regions during the retrieval of well-consolidated emotional memories.

While such studies are basic in nature, said Cabeza, better delineation of the role of the amygdala in emotional memory could aid understanding of post traumatic stress disorder -- especially such phenomena as flashbacks of traumatic memories. Said Dolcos, "Also, people who suffer depression ruminate obsessively on negative or unpleasant memories. This problem could reflect a pathology in how their memory systems have processed emotional memories."

Thus, said Cabeza, he and his collaborators are now exploring the nature of emotional memory encoding in people with depression, before and after therapy.




NUTRITION NEWS




Cilantro May Prevent Food Poisoning

by Dr. Joseph Mercola

A study revealed that cilantro, an herb that is commonly used to add flavor to several kinds of Mexican dishes, contains a compound that could help prevent food borne illnesses such as salmonella. The compound is called dodecenal and is found in the leaves and seeds of cilantro. Researchers found that dodecenal was twice as strong and more effective than gentamicin, a widely used antibiotic treatment for salmonella.

Based on these findings researchers suggested the possibility of using dodecenal as a tasteless food additive to help guard against food-borne illnesses. Researchers suggested using it to create a layer of protection over meat at processing plants or as a possible all-purpose cleaning and hand-washing agent.

It was also discovered that cilantro contained as many as a dozen other antibiotic compounds.

Researchers cautioned individuals not to rely solely on salsa to protect them from food-borne illnesses and instead recommended individuals take the proper precautions with the storing and handling of any food. It is believed that the compound was effective at helping prevent food-borne illnesses because it killed off the cell membrane of the bacteria.

Journal of Agricultural and Food Chemistry June 2, 2004;52(11):3329-32



 
Researchers Believe Diet Rich in Omega-3 Fatty Acids May Help Decrease Aches and Pains Associated With Arthritis

June 14, 2004 - (HealthNewsDigest.com)...Arthritis is the leading cause of physical disability in the United States, according to the Center for Disease Control and Prevention. One of the most common forms of the disease is rheumatoid arthritis, which causes inflammation in the lining of the joints and afflicts more than two million Americans - mostly women.

A growing body of research indicates that adding omega-3 fatty acids to the diet, such as those found in fatty fish like herring, salmon and tuna, may play an important role in alleviating the painful symptoms of rheumatoid arthritis.(1) Scientists believe that omega-3 fatty acids may not only reduce the symptoms of the disease and potentially facilitate individuals taking lower doses of anti-inflammatory drugs, omega-3s also appear to help preserve overall joint function.

Scientists first made the omega-3 connection with joint disease by observing populations like Greenland's Inuits. This indigenous population consumes eight to 12 grams of omega-3s a day and demonstrate a significantly lower incidence of arthritic symptoms, as compared to Americans.

However, getting enough omega-3s from eating fish can be a challenge for Americans who don't have access to fatty fish, are worried about fish contamination or simply don't prefer the taste.

A recent survey of US households, conducted by ICR Survey Research Group, found that Americans are less likely to eat fresh fish than many other foods.

Nearly half (48%) of those surveyed said their number one reason for avoiding fresh fish was the fear of contaminants like mercury or PCBs.

"The benefits of omega-3s for arthritic symptoms such as joint pain and stiffness are well documented," said Dr. Morten Bryhn, M.D., Ph.D, medical director for Pronova Biocare, the world's top producer of marine-based omega-3 fatty acids. "In order to gain these benefits, Americans need to increase their intake of omega-3s by regularly including fatty fish in their diets or by taking a highly concentrated omega-3 fish oil supplement, with at least 70%

omega-3s."

Those interested in taking an omega-3 supplement are advised to look for a supplement that contains both EPA and DHA, the most important of the omega-3 fatty acids. They should also make sure that the fish oil they choose is highly concentrated and purified, providing at least 70% omega-3s.

Reference

(1) Fortin PR et al. Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. J Clin Epidemiol 1995;48:1379-1390.






Thank you for Visiting the On Demand NewsLetter...Please feel free to email this news letter to a friend.

Thank You,
The CrossRoads Team

| Home | Newsletter Archives